ROSE_2A: ROSE, figure 2A

ROSE_2AR Documentation

ROSE, figure 2A

Description

Kaplan-Meier digitized data from ROSE, figure 2A (PMID 25185099). A reported sample size of 1,144 for a primary endpoint of PFS in breast cancer.

Usage

ROSE_2A

Format

A data frame of 1,144 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (pbo_doc, ram_doc)

Source

Mackey JR, Ramos-Vazquez M, Lipatov O, et al. Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer. J Clin Oncol 2015; 33: 141–8.

Examples

summary(ROSE_2A)

kmplot(ROSE_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.